Trial Profile
Sympathetic and cardiovascular changes induced by sodium oxybate treatment in patients with narcolepsy and cataplexy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Dec 2015
Price :
$35
*
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Catalepsy; Narcolepsy
- Focus Therapeutic Use
- 25 Dec 2015 New trial record